These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9211637)
21. Ex vivo expansion of human cytomegalovirus-specific cytotoxic T cells by recombinant polyepitope: implications for HCMV immunotherapy. Rist M; Cooper L; Elkington R; Walker S; Fazou C; Tellam J; Crough T; Khanna R Eur J Immunol; 2005 Mar; 35(3):996-1007. PubMed ID: 15726667 [TBL] [Abstract][Full Text] [Related]
22. Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation. Chen J; Zajac AJ; McPherson SA; Hsu HC; Yang P; Wu Q; Xu X; Wang X; Fujihashi K; Curiel DT; Mountz JD Gene Ther; 2005 Jul; 12(13):1079-88. PubMed ID: 15815704 [TBL] [Abstract][Full Text] [Related]
23. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. Liu L; Flaño E; Usherwood EJ; Surman S; Blackman MA; Woodland DL J Immunol; 1999 Jul; 163(2):868-74. PubMed ID: 10395681 [TBL] [Abstract][Full Text] [Related]
24. Enhanced generation of cytotoxic T lymphocytes by increased cytosolic delivery of MHC class I epitope fused to mouse heat shock protein 70 via polyhistidine conjugation. Takemoto S; Nishikawa M; Otsuki T; Yamaoka A; Maeda K; Ota A; Takakura Y J Control Release; 2009 Apr; 135(1):11-8. PubMed ID: 19100299 [TBL] [Abstract][Full Text] [Related]
25. Evasion of cytotoxic T lymphocytes by murine cytomegalovirus. Kavanagh DG; Hill AB Semin Immunol; 2001 Feb; 13(1):19-26. PubMed ID: 11289796 [TBL] [Abstract][Full Text] [Related]
26. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337 [TBL] [Abstract][Full Text] [Related]
28. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells. Hiltbold EM; Alter MD; Ciborowski P; Finn OJ Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817 [TBL] [Abstract][Full Text] [Related]
29. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides. Laus R; Graddis TJ; Hakim I; Vidovic D Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805 [TBL] [Abstract][Full Text] [Related]
35. [Double infections due to herpesviruses and adenoviruses in infants' communities]. Holý J; Vanĕcek K Cesk Pediatr; 1974 Apr; 29(4):182-5. PubMed ID: 4364570 [No Abstract] [Full Text] [Related]
36. Mechanisms of interference with the MHC class I-restricted pathway of antigen presentation by herpesviruses. Hill AB Immunol Cell Biol; 1996 Dec; 74(6):523-6. PubMed ID: 8989590 [TBL] [Abstract][Full Text] [Related]
37. Cytotoxic T lymphocytes in herpesvirus infections. Rouse BT; Horohov DW Vet Immunol Immunopathol; 1984 May; 6(1-2):35-66. PubMed ID: 6330966 [No Abstract] [Full Text] [Related]
38. [Study of the conversion rates to Adenoviruses and Herpesviruses in an infants' community (author's transl)]. Holý J; Vanĕcek K; Pavlík Z Cesk Epidemiol Mikrobiol Imunol; 1975 Jan; 24(1):15-21. PubMed ID: 165903 [No Abstract] [Full Text] [Related]
39. [Role of the reticuloendothelial system in the development of some experimental virus infections]. Maksimovich NA; Suptel' EA Dokl Akad Nauk SSSR; 1971 Jan; 196(2):451-4. PubMed ID: 4324724 [No Abstract] [Full Text] [Related]